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The CaMKII/NMDA receptor complex controls
hippocampal synaptic transmission by kinase-
dependent and independent mechanisms
Salvatore Incontro1, Javier Díaz-Alonso1, Jillian Iafrati2, Marta Vieira3, Cedric S. Asensio 4, Vikaas S. Sohal2,
Katherine W. Roche3, Kevin J. Bender5 & Roger A. Nicoll1,6
CaMKII is one of the most studied synaptic proteins, but many critical issues regarding its
role in synaptic function remain unresolved. Using a CRISPR-based system to delete CaMKII
and replace it with mutated forms in single neurons, we have rigorously addressed its various
synaptic roles. In brief, basal AMPAR and NMDAR synaptic transmission both require
CaMKIIα, but not CaMKIIβ, indicating that, even in the adult, synaptic transmission is
determined by the ongoing action of CaMKIIα. While AMPAR transmission requires kinase
activity, NMDAR transmission does not, implying a scaffolding role for the CaMKII protein
instead. LTP is abolished in the absence of CaMKIIα and/or CaMKIIβ and with an autop-
hosphorylation impaired CaMKIIα (T286A). With the exception of NMDAR synaptic cur-
rents, all aspects of CaMKIIα signaling examined require binding to the NMDAR, emphasizing
the essential role of this receptor as a master synaptic signaling hub.
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Calcium-calmodulin-dependent protein kinase II (CaMKII),one of the first proteins identified in the postsynapticdensity (PSD), has remained a focus of intense research
ever since1–4. In the forebrain CaMKII consists of heteromers of
alpha and beta subunits, with an excess of CaMKIIα compared to
CaMKIIβ5. The protein is present in unusually high amounts for
a kinase, which led to an early hypothesis that it also has a
structural role. CaMKII is inactive under resting conditions, as
substrate access to its binding site in the catalytic domain is
blocked by the autoinhibitory pseudosubstrate of the protein4,6,7.
Ca2+ influx through synaptic N-metil-D-aspartate receptors
(NMDARs) binds to calmodulin (CaM), which then binds to the
pseudosubstrate segment of CaMKII, relieving autoinhibition1,6,8.
When Ca2+/CaM binds, autophosphorylation of CaMKIIα at
T286 results in kinase activity that persists after removal of Ca2
+/CaM6,7. These properties have made CaMKII an extremely
popular molecular model for information storage. Indeed, both
pharmacological blockade of CaMKII9–11 and genetic deletion of
CaMKII12–14 strongly reduce NMDAR-dependent long-term
potentiation (LTP), but rarely eliminate it, raising the possibility
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of a CaMKII-independent component to LTP. Expression of
exogenous constitutively active CaMKII closely mimics LTP15–17,
suggesting that it is sufficient for LTP.
Most studies have focused on CaMKII’s enzymatic role at
excitatory synapses; however, kinase-independent structural roles
for CaMKII have recently emerged3. These structural roles appear
to depend on CaMKIIβ, which localizes to the post-synaptic
density (PSD) through interactions with F-actin18–20. For
instance, the morphological effects of deleting CaMKIIβ can be
rescued by expressing a kinase dead mutant of CaMKIIβ20. In
addition, the impairment of CaMKIIα targeting to the PSD in the
CaMKIIβ KO mouse is not observed in a knockin mouse
expressing the Thr286 autophosphorylation null CaMKIIα
mutant (T286A)21. Thus it has been postulated that the two
CaMKII subunits serve separate roles, with CaMKIIα being pri-
marily recruited to the PSD in an activity-dependent manner
during LTP1,2, whereas CaMKIIβ stabilizes the actin cytoskeleton.
Given these dual roles, one would suspect that CaMKII con-
tributes both to changes in synaptic strength as well as basal
synaptic transmission. Nevertheless, the effect, if any, that
CaMKII has on basal synaptic transmission is confusing. Phar-
macological blockade of CaMKII has mixed effects on baseline
transmission9,10,22–25, whereas complete deletion of CaMKIIα
either in the germline KO12 or in the adult conditional KO26 has
no effect on basal transmission. Furthermore, while knockin of
the Thr286 autophosphorylation null CaMKIIα mutant13 or a
kinase dead mutant14 inhibits LTP, it does not alter baseline
transmission. Overall, these results suggest that CaMKII is not
required for normal synapse development or basal synaptic
strength. Rather it is specifically dedicated to LTP.
It is clear that while CaMKII has remained a central focus of
studies on synaptic plasticity for over two decades, many unre-
solved issues remain. In the present study we have used a
CRISPR-based system to address many of these issues. Deleting
CaMKIIα acutely caused a dramatic reduction in α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)
excitatory post-synaptic currents (EPSCs) and a modest reduction
in NMDAR EPSCs. Replacement of wild-type (WT) CaMKIIα
with autophosphorylation impaired CaMKIIα T286A and kinase
impaired CaMKIIα K42R failed to rescue the AMPAR defect, but
did rescue the NMDAR defect, indicating that maintenance of
basal AMPAR transmission, but not NMDAR transmission,
requires CaMKIIα activity. The blockade of LTP by deleting
CaMKIIα was not secondary to the reduction in NMDAR EPSCs,
because when NMDAR currents are rescued by replacing endo-
genous CaMKIIα with mutated forms, LTP was still prevented.
Our findings have clearly delineated both enzymatic and struc-
tural roles for CaMKII in maintaining basal synaptic transmission
in addition to its essential role in synaptic plasticity. Finally,
disrupting the binding of CaMKII to NMDARs abolishes all
examined actions of CaMKII, except its ability to rescue NMDAR
synaptic currents. Our results demonstrate the unappreciated role
of CaMKII in basal transmission and clarify the literature by
delineating the relative contributions of CaMKIIα and CaMKIIβ
in our KO system. We demonstrate the central role of the
CaMKII/NMDAR protein complex as a key-signaling hub, con-
trolling numerous fundamental aspects of excitatory synaptic
transmission.
Results
The role of CaMKII in basal synaptic transmission and LTP.
We first designed a number of guide RNAs (gRNAs) against
CaMKIIα and CaMKIIβ. To test their effectiveness we expressed
these gRNAs together with Cas9 (Fig. 1a) with lentivirus in dis-
sociated neuronal cultures. We identified two gRNAs that were
highly effective in eliminating CaMKIIα protein (Fig. 1b) and one
gRNA highly effective against CaMKIIβ (Fig. 1b). We also ver-
ified these gRNAs with immunofluorescence in dissociated neu-
ronal cultures and found little detectable protein for either
CaMKIIα (Fig. 1c−e) or CaMKIIβ (Fig. 1f−h) in transfected cells.
Next, we coated gold particles with Cas9 and the gRNA, biolis-
tically delivered them to hippocampal slice cultures and waited 10
−12 days before recording (Fig. 1a, bottom) (see Methods).
Simultaneous paired recordings were made from a transfected cell
and a neighboring control cell, while stimulating a common
population of excitatory afferents (Fig. 1a, bottom). AMPAR
EPSCs were recorded at −70 mV and NMDAR EPSCs were
recorded at +40 mV and measured at 100 ms after the stimulus to
ensure no contamination from the AMPARs. Deleting CaMKIIα
reduced the AMPAR EPSC by approximately 50% (Fig. 1i, l) and
the NMDAR EPSC by 30% (Fig. 1m, p). No change in paired
pulse ratio, a measure of presynaptic release probability, was seen
(Supplementary Fig. 1a, b). Furthermore there was no change in
the decay kinetic of the pharmacologically isolated NMDAR
EPSC (Supplementary Fig. 1c). The AMPA/NMDA ratio was
reduced (Supplementary Fig. 1d), as expected, since the reduction
in AMPAR currents was more severe than the reduction in the
NMDAR currents. Deletion of CaMKIIβ had no effect on
AMPAR EPSCs (Fig. 1j, l) or on NMDAR EPSCs (Fig. 1n, p).
Deletion of both CaMKIIα and CaMKIIβ (DKO) resulted in a
further decrease in the AMPAR EPSC (Fig. 1k, l), but no further
decrease in the NMDAR EPSC (Fig. 1o, p).
What is the relative importance of the two CaMKII subunits in
synaptic plasticity? In our hands LTP of evoked EPSCs is
unreliable in slice culture. Thus, for these experiments we turned
to in utero electroporation in mice at embryonic day 15 (E15),
Fig. 1 CaMKIIα is required for basal synaptic transmission. a Timeline of experiment, map of the CRISPR constructs transfected biolistically and scheme of
the electrophysiological approach. The confocal image caption shows an example of a transfected pyramidal neuron. Scale bar 10 μm. b Western blot for
CaMKII α and β isoforms from dissociated neuronal cultures infected with lentiCRISPR for the respective isoform. Images have been cropped for
presentation. Full size images are presented in supplementary Fig. 11. c−h Immunofluorescence in dissociated neuronal cultures transfected with
CRISPR_CaMKIIα (red channel) and detected with CaMKIIα antibody (green channel) (c–e) or transfected with CRISPR_CaMKIIβ (red channel) and
detected with CaMKIIβ antibody (green channel) (f−h). Scale bar 10 μm. i−k Scatterplots show amplitudes of AMPAR EPSC for single pairs (open circles)
of control and transfected cells of CRISPR_CaMKIIα (i, n= 32 pairs), CRISPR_CaMKIIβ (j, n= 17 pairs) and CRISPR_DKO (k, n= 46 pairs). Filled circles
indicate mean amplitude ± SEM (i, Control= 116.3 ± 9.6; CRISPR_CaMKIIα= 58.03 ± 6.1, p < 0.0001. j, Control= 106.6 ± 11.6; CRISPR_CaMKIIβ= 109.6 ±
19.66, p= 0.90. k, Control= 106.6; CRISPR_DKO= 49.3 ± 3.4, p < 0.0001). l Bar graph of ratios normalized to control (%) summarizing the mean ± SEM
of AMPAR EPSCs for values represented in i (56.18 ± 5, p < 0.0001), j (98.23 ± 10, p= 0.58) and k (41.6 ± 3.2, p < 0.0001). m−o Scatterplots show
amplitudes of NMDAR EPSCs for single pairs (open circles) of control and transfected cells of CRISPR_CaMKIIα (m, n= 29 pairs), CRISPR_CaMKIIβ (n, n
= 17 pairs) and CRISPR_DKO (o, n= 44 pairs). Filled circles indicate mean amplitude ± SEM (m, Control= 45.5 ± 3.4; CRISPR_CaMKIIα= 28.2 ± 2.2, p=
0.0001. n, Control= 47.3 ± 8.5; CRISPR_CaMKIIβ= 45.6 ± 8.7, p= 0.88. o, Control= 72 ± 4.6; CRISPR_DKO= 44.3 ± 3.2, p < 0.0001). p Bar graph of
ratios normalized to control (%) summarizing the mean ± SEM of NMDAR EPSCs for values represented in m (74.8 ± 7, p= 0.0003), n (109.7 ± 16, p=
0.75) and o (66 ± 5, p < 0.0001). Raw amplitude data from dual cell recordings (scatterplots) were analyzed using Wilcoxon signed rank test (p values
indicated above). Normalized data (bar graphs) were analyzed using a one-way ANOVA and p values were calculated with the Mann−Whitney test (***p
< 0.0001; *p < 0.05). Scale bars: 50ms, 50 pA. See also Supplementary Fig. 1
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making acute slices at P20−28 (Fig. 2a). Loss of CaMKIIα
resulted in a substantial decrease in the AMPAR EPSC (Fig. 2b),
confirming our slice culture results. LTP, induced by a pairing
protocol, was absent (Fig. 2c). It is important to note that, as in a
previous study from this lab27, there was a variable, but
systematic, run up of the EPSCs (~50%) either when pairing
was carried out in the presence of APV (Supplementary Fig. 2) or
when no pairing was performed27. Experiments in the presence of
APV were interleaved throughout this study, which were
averaged together and this APV-insensitive run up is plotted
(light gray circles) in all of the LTP graphs. Although in utero
deletion of CaMKIIβ had no effect on basal synaptic transmission
(Fig. 2d), confirming our results in slice culture, it did block LTP
(Fig. 2e), similar to the deletion of CaMKIIα. In utero deletion of
both CaMKIIα and CaMKIIβ recapitulated the large depression
in AMPAR EPSCs (Fig. 2f) and LTP was absent (Fig. 2g).
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To determine the relative importance of CaMKIIα and
CaMKIIβ in baseline transmission and LTP, we attempted to
rescue the defects caused by the DKO by expressing back CaMKII
subunits (Fig. 3a, b). CaMKIIα fully rescued both the AMPAR
(Fig. 3c, e) and NMDAR EPSCs (Fig. 3f, h). To examine LTP we
used in utero electroporation (Fig. 3i). CaMKIIα fully rescued
LTP (Fig. 3j) in the DKO, indicating that CaMKIIβ is not
required for the full expression of LTP. In contrast to CaMKIIα,
the depression in synaptic transmission caused by the DKO was
only partially rescued by expression of CaMKIIβ (Fig. 3d, e, g, h).
Furthermore, CaMKIIβ was unable to rescue LTP, either in the
DKO (Fig. 3k) or in the CaMKIIα deletion (Supplementary
Fig. 3b). These findings with CaMKIIβ are consistent with the
lower expression levels of this isoform under normal conditions,
and further suggest that it is not as effective as CaMKIIα in
maintaining basal synaptic transmission or LTP. One concern is
the presence of multiple splice variants of CaMKIIβ28 all of which
are deleted by CRISPR. Perhaps the failure to rescue the defects
observed with deleting CaMKIIβ is that the splice variant we
use29 is unable to substitute for all of the other slice variants. To
test for this scenario, we deleted CaMKIIβ and then asked
whether expression of our CaMKIIβ construct could fully rescue
LTP. Indeed, there was a full rescue of LTP (Supplementary
Fig. 3c).
Are the effects of deleting CaMKII restricted to an early
developmental stage when synaptogenesis is high, or is CaMKII
required for maintaining synaptic function at mature synapses?
To address this we repeated the DKO experiments in the adult
hippocampus by expressing the gRNA with lentivirus in CA1
pyramidal cells (Fig. 4a, b) in the Cas9 knockin mouse30.
Simultaneous paired recordings were made from a transfected cell
and a neighboring control cell (Fig. 4c). We found the same
depression in both AMPAR (Fig. 4d, e) and NMDAR synaptic
responses (Fig. 4f, g). LTP was also abolished in these cells
(Fig. 4h). We also analyzed the effect of lentivirus-mediated
expression of CaMKII DKO gRNA in dentate gyrus (Fig. 4i). The
results, both in terms of basal AMPAR transmission (Fig. 4j, k)
and LTP (Fig. 4l), were identical to those observed in the CA1
region. These findings indicate that CaMKII is required to
maintain synaptic transmission at stable adult synapses.
The role of kinase activity in the actions of CaMKIIα. Many
studies have suggested that, in addition to its role as a kinase,
CaMKII also has a structural/scaffolding component. To distin-
guish between these two components we first examined the role
of CaMKIIα by expressing two different mutated CaMKIIα
constructs in the DKO background (Fig. 5a, b). Expression of the
Thr286 autophosphorylation null CaMKIIα T286A13,31 or kinase
dead CaMKIIα K42R32 mutants failed to rescue the AMPAR
defect (Fig. 5c−e), but fully rescued the NMDAR defect (Fig. 5f
−h). These results indicate that CaMKIIα basal kinase activity is
required to maintain AMPAR-dependent synaptic transmission.
On the other hand, CaMKIIα-dependent maintenance of the
NMDAR EPSC is entirely independent of kinase activity, sug-
gesting a structural/scaffolding role. It is important to note that
the inability to rescue the AMPAR EPSC is not due to the lack of
expression of the CaMKIIα mutants, because there was a full
rescue of the NMDAR EPSC. Immunofluorescence experiments
in dissociated neuronal cultures confirm the decrease in surface
GluN2B containing receptors in the DKO background (Supple-
mentary Fig. 4a−c). This phenotype is rescued by both WT
CaMKIIα and mutants (CaMKIIα T286A and CaMKIIα K42R).
Given the profound effects of CaMKIIα and CaMKIIβ deletion
on excitatory synaptic function, we used super-resolution
microscopy to examine the morphology of dendritic spines
(Supplementary Fig. 4d), which receive the large majority of
excitatory synapses (Supplementary Fig. 4e). Although there was
no change in the density of spines (Supplementary Fig. 4e, f), we
found a substantial reduction in head diameter (Supplementary
Fig. 4e, g) and an increase in the length of the spine neck
(Supplementary Fig. 4e, h). Expression of CaMKIIα K42R rescued
the DKO effect on spine neck, but not on the head diameter
(Supplementary Fig. 4e−h), indicating that kinase activity is
required for maintaining spine head diameter. Given the
correlation between spine size and number of AMPARs33–35,
one might expect a decrease in the size of miniature EPSCs
(mEPSCs) in cells lacking CaMKII. Indeed, we recorded a
significant reduction in the amplitude of mEPSCs, but no change
in frequency (Supplementary Fig. 1e−l), consistent with the
conserved spine density.
To further elucidate the role of CaMKII in spine morphology,
we analyzed structural LTP (sLTP) using two-photon glutamate
uncaging in organotypic slices biolistically transfected with GFP,
gRNAs, and Cas9 (and CaMKIIα T286A for replacement).
Employing an established sLTP protocol consisting of 30 pulses
of glutamate uncaging at 0.5 Hz, in the absence of Mg2+36,37, we
analyzed changes in spine volume in the WT, CaMKII DKO, and
CaMKIIα T286A replacement. We confirmed (Fig. 5i−k) that
sLTP consists of a fast transient phase with a large increase in
spine volume, which lasts for approximately 8 min, followed by a
long-term 1.5-fold enhancement phase37. We repeated these
experiments in CaMKII DKO transfected neurons and found
Fig. 2 Elimination of CaMKII blocks LTP. a Experimental timeline. b Scatterplot and bar graph of ratios normalized to control of the AMPAR EPSCs for single
pairs (open circles) of control and transfected CRISPR_CaMKIIα cells. Filled circle represents mean amplitude ± SEM (Control= 127.3 ± 28.9;
CRISPR_CaMKIIα= 67.29 ± 12.7, n= 8 pairs, p= 0.015). Bar graph of ratios normalized to control (%) summarizing the mean ± SEM of AMPAR EPSCs (51
± 5, p < 0.001). c Plots show mean ± SEM AMPAR EPSC amplitude of control (black) and transfected (green) CRISPR_CaMKIIα pyramidal neurons
normalized to mean AMPAR EPSC amplitude before LTP induction (arrow) (Control, n= 6; CRISPR_CaMKIIα, n= 7, p= 0.029 at 35min). d Scatterplot
and bar graph of ratios normalized to control of the AMPAR EPSCs for single pairs (open circles) of control and transfected CRISPR_CaMKIIβ cells. Filled
circle represents mean amplitude ± SEM (Control= 140.4 ± 21.4; CRISPR_CaMKIIβ= 143.5 ± 21.7, n= 8 pairs, p= 0.84). Bar graph of ratios normalized to
control (%) summarizing the mean ± SEM of AMPAR EPSCs (102 ± 15, p= 0.87). e Plots show mean ± SEM AMPAR EPSC amplitude of control (black) and
transfected (green) CRISPR_CaMKIIβ pyramidal neurons normalized to the mean AMPAR EPSC amplitude before LTP induction (arrow) (Control, n= 7;
CRISPR_CaMKIIβ, n= 7, p= 0.011 at 35min). f Scatterplot and bar graph of ratios normalized to control of the AMPAR EPSCs for single pairs (open
circles) of control and transfected CRISPR_DKO cells. Filled circle represents mean amplitude ± SEM (Control= 81.9 ± 9.4; DKO= 39.1 ± 6.43, n= 11 pairs,
p= 0.001). Bar graph of ratios normalized to control (%) summarizing the mean ± SEM of AMPAR EPSCs (102 ± 15, p < 0.001). g Plots show mean ± SEM
AMPAR EPSC amplitude of control (black) and transfected (red) CRISPR_DKO pyramidal neurons normalized to the mean AMPAR EPSC amplitude before
LTP induction (arrow) (Control, n= 13; CRISPR_DKO, n= 8, p= 0.0084 at 35min). Gray plots represent mean ± SEM AMPAR EPSC amplitude of LTP
induction in APV 50 μM. Sample AMPAR EPSC current traces from control (black) and electroporated neurons (green or red) before and after LTP are
shown to the right of each graph. Raw amplitude data from dual cell recordings were analyzed using Wilcoxon signed rank test (p values indicated above).
Normalized data were analyzed using a one-way ANOVA followed by a Mann−Whitney test to calculate p values (**p < 0.001). Mann−Whitney test was
used also to compare LTP at 35 min (p values indicated above). Scale bars: 50ms, 50 pA. See also Supplementary Fig. 3
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04439-7 ARTICLE
NATURE COMMUNICATIONS |          (2018) 9:2069 | DOI: 10.1038/s41467-018-04439-7 | www.nature.com/naturecommunications 5
that the transient phase remained intact, while the stable
enhancement was abolished (Fig. 5i, j and Supplementary
Fig. 5d). The same result was obtained in CaMKIIα ΚO
(Supplemental Fig. 5f, h, i, k) and CaMKIIβ KO neurons
(Supplementary Fig. 5g, h, j, k), highlighting the importance of
CaMKIIβ in sLTP. These results strongly confirm our data
obtained in electrophysiology experiments (Fig. 2e). What, then,
is required for sLTP? Application of NMDAR inhibitors CPP or
APV, before uncaging glutamate abolished spine volume changes
as expected (Supplementary Fig. 6a, c, f). To determine if Ca2+ is
required, we repeated the experiment in WT GFP neurons in a
solution that prevented Ca2+ influx (nominally 0 Ca2+ with
EGTA 10 mM). This treatment completely prevents sLTP
(Supplementary Fig. 6d, f). To confirm that this process is
strictly dependent on Ca2+, we switched the solution to one
containing Ca2+ (4 mM) and measured sLTP from neighbor
spines. sLTP was fully rescued by Ca2+ (Supplementary Fig. 6e,
f). Finally we induced sLTP in neurons expressing CaMKIIα
T286A GFP : the transient phase is identical to WT, but long-
term sLTP is not maintained (Fig. 5i−k and Supplementary
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Fig. 5e). These results indicate that CaMKIIα activity is necessary
for long-term sLTP, but is not for transient sLTP.
The results in Fig. 2 indicate that deleting CaMKII blocks LTP.
However, it is important to note that the NMDAR EPSC is also
reduced, raising the possibility that the blockade in LTP is
secondary to the effect on NMDARs. To address this issue we took
advantage of the CaMKIIα mutations (T286A and K42R), which
fully rescue the NMDAR current (Fig. 5f−h). Thus we carried out
an additional series of in utero electroporation experiments using
the DKO strategy (Fig. 6a, b). Similar to the slice culture results,
both the AMPAR (Fig. 6g) and NMDAR EPSCs (Fig. 6c, e) were
substantially reduced. We then examined the ability of CaMKIIα
mutants, T286A and K42R, to rescue basal transmission and LTP.
In agreement with our results in slice culture CaMKIIα T286A
failed to rescue the AMPAR EPSCs (Fig. 6f, g), but it fully rescued
the NMDAR EPSC (Fig. 6d, e). In cells expressing the T286A
mutant LTP was blocked (Fig. 6h). This finding indicates that the
reduction in the NMDAR function in the CaMKII deletions
cannot account for the blockade of LTP (Fig. 2) and that CaMKIIα
kinase activity is, indeed, essential for LTP. In utero electropora-
tion of CaMKIIα K42R had the same effects as CaMKIIα T286A
on baseline synaptic transmission (Supplementary Fig. 7b−e), but
the effects on LTP (Supplementary Fig. 7f) were not as dramatic as
the effects of the CaMKIIα T286A mutant.
The synaptic actions of CaMKII require binding to NMDARs.
Considerable evidence has demonstrated that CaMKII binds to
NMDARs38–40 and accumulates at postsynaptic sites40,41. Resi-
dues within the GluN2B C-terminal tail that are critical for this
interaction have been mapped, and either overexpression42 or
knockin of mutants43 disrupting CaMKII binding impairs LTP.
Two adjacent sites on the kinase domain of CaMKII, termed the
S-site and T-site, are required for the binding to NR2B. An initial
weak S-site occupation is followed by a more stable interaction
with the T-site40. We adopted two different critical mutations in
CaMKIIα to prevent NR2B binding: F98K (S-site) and I205K (T-
site). The physiological consequences of mutating these two cri-
tical sites on CaMKIIα40,44 (Fig. 7b) remain unknown. We
expressed the F98K and I205K mutants on the DKO background
in slice culture (Fig. 7a, b). Remarkably, we find that, although the
kinase activity of these mutants is normal40,44, their effects were
identical to CaMKIIα T286 and CaMKIIα K42R mutants, failing
to rescue AMPAR EPSCs (Fig. 7c, d, f), but fully rescuing
NMDAR EPSCs (Fig. 7g, h, j). Combining the CaMKIIα I205K
mutation with the kinase dead mutation (K42R) yielded result
indistinguishable from the I205K mutation on its own (Fig. 7e, f,
i, j). These results suggest that CaMKIIα binding to the NMDAR
is essential for CaMKII to affect synaptic transmission. In
contrast to the negative results with the CaMKIIα F98K and
I205K mutants, expression of WT CaMKIIα fully rescued the
defects caused by deleting endogenous CaMKII (Fig. 7f, j). We
next examined the effect of disrupting the binding of CaMKIIα to
NMDARs on LTP. We used in utero electroporation (Fig. 8a) of
the CaMKIIα I205K mutant (Fig. 8b) on the DKO background
and recorded from acute slices at P20-28. Similar to the results in
slice culture, the I205K mutant failed to rescue baseline AMPAR
transmission (Fig.8c, d), but rescued NMDAR transmission
(Fig. 8e, f). Preventing CaMKII binding to NMDARs abolished
LTP (Fig. 8g).
While the CaMKIIα F98K and I205K mutations block the
binding of CaMKII to the GluN2B receptor40,44, they also affect
binding to itself45 as well as other proteins such as densin46 and
GluN147. These others binding deficits could explain the more
dramatic effects we observe on LTP compared to previous results
in which mutations were made in the GluN2B subunits42,43. To
compare more directly our results to earlier studies, we carried
out a series of molecular replacement experiments with the
GluN2B subunit (Fig. 9a, b). Deleting GluN2B causes a dramatic
reduction in the NMDAR EPSCs (Fig. 9g, l) and an enhancement
of AMPAR EPSCs (Fig. 9c, k), as expected from previous
results48. We next attempted to rescue the changes by expressing
wild-type GluN2B. In this case the NMDAR current was fully
rescued (Fig. 9h, l) and there was no change in the AMPAR
current (Fig. 9d, k). The expression of the mutant form of
GluN2B that abolishes the binding of CaMKIIα (Fig. 9a, b)43 fully
rescued the NMDAR EPSC (Fig. 9i, l), demonstrating that this
mutation had no effect on the function of the NMDAR.
Importantly, the AMPAR EPSCs are reduced (Fig. 9e, k) to an
extent like that seen with the Thr286 autophosphorylation null
mutant of CaMKIIα (T286A) (Fig. 9k). This finding indicates that
the binding of CaMKIIα to the NMDAR is necessary for its role
in maintaining basal synaptic transmission. Finally, and most
importantly, the dramatic enhancement of synaptic transmission
observed with the kinase active CaMKIIα T305A/T306A muta-
tion (Fig. 9k) (see below) is entirely prevented (Fig. 9f, k).
NMDAR EPSCs in the CaMKIIα T305A/T306A replacement
were not different from control (Fig. 9j). Together these findings
establish that for CaMKII to have any effect on synaptic function,
except for its effects on NMDARs, it must be docked at the PSD
by its binding to the NMDAR.
CaMKII constitutive activity and the maintenance of LTP. One
of the most controversial aspects of CaMKII function is whether
it can maintain LTP following the transient rise in calcium during
the induction of LTP. It has previously been shown that autop-
hosphorylation of CaMKIIα on T305 and T306 in the Ca2+
Fig. 3Molecular replacement confirms the key role of CaMKIIα. a Timeline of the experiment. b Representative maps of constructs. c, d Scatterplots show
amplitudes of AMPAR EPSCs for single pairs (open circles) of control and transfected cells of DKO+CaMKIIα (c, n= 11 pairs) and DKO+ CaMKIIβ (d, n
= 26 pairs). Filled circles indicate mean amplitude ± SEM (c, Control= 90.8 ± 16.8; DKO+ CaMKIIα= 88.6 ± 13.2, p= 0.96; d, Control= 111.1 ± 9; DKO+
CaMKIIβ= 71.2 ± 7.9, p= 0.002). e Bar graph of ratios normalized to control (%) summarizing the mean ± SEM of AMPAR EPSCs of values represented in
c (132 ± 30, p= 0.76) and d (66 ± 6, p= 0.0009). DKO data (red bar) from Fig. 1l are included in the graph. f−h Scatterplots show amplitudes of NMDAR
EPSCs for single pairs (open circles) of control and transfected cells of DKO+ CaMKIIα (f, n= 11 pairs) and DKO+ CaMKIIβ (g, n= 26 pairs). Filled circles
indicate mean amplitude ± SEM (f, Control= 43.5 ± 8.4; DKO+CaMKIIα= 38.7 ± 9.5, p= 0.51; g, Control= 63.4 ± 7; DKO+ CaMKIIβ= 49.5 ± 5,
p= 0.078). h Bar graph of ratios normalized to control (%) summarizing the mean ± SEM of NMDAR EPSCs of values represented in f (114 ± 24, p= 0.76)
and g (82 ± 7, p= 0.09). DKO data (red bar) from Fig. 1p are included in the graph. i Timeline of the in utero electroporation experiment. j Plots show
mean ± SEM AMPAR EPSC amplitude of control (black) and transfected (green) DKO+CaMKIIα pyramidal neurons normalized to the mean AMPAR
EPSC amplitude before LTP induction (arrow) (Control, n= 5; DKO+CaMKIIα, n= 8, p= 0.289 at 35 min). k Plots show mean ± SEM AMPAR EPSC
amplitude of control (black) and transfected (green) DKO+ CaMKIIβ pyramidal neurons normalized to the mean AMPAR EPSC amplitude before LTP
induction (arrow) (Control, n= 5; DKO+ CaMKIIβ, n= 5, p= 0.017 at 35min). Gray plots represent mean ± SEM AMPAR EPSC amplitude of LTP
induction in APV 50 μM. Raw amplitude data from dual cell recordings were analyzed using Wilcoxon signed rank test (p values above). Normalized data
were analyzed using a one-way ANOVA and p values calculated with the Mann−Whitney test (***p < 0.0001; **p < 0.001; *p < 0.05). Mann–Whitney test
was used also to compare LTP at 35min (p values indicated above). Scale bars: 50ms, 50 pA. See also Supplementary Fig. 3
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/CaM binding domain (Supplementary Fig. 8b) prevents activa-
tion by Ca2+/CaM49,50, whereas preventing phosphorylation of
these residues greatly enhances Ca2+/CaM-driven CaMKII
activity51,52. We found that CaMKIIα, in which either T305, or
T306, or both were mutated to aspartate, thus mimicking
phosphorylation, all failed to rescue AMPAR currents in the
DKO (Supplementary Fig. 8c−f), although they all fully rescued
the NMDAR currents (Supplementary Fig. 8g−j). These results
confirm that these two amino acids are critical for the Ca2+/CaM
activation of CaMKIIα.
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We next examined the phospho null mutants (T305A/T306A),
by overexpressing them on a WT background (2–3 days). We
compared the effects of WT CaMKIIα, CaMKIIα T286D-T305A/
T306A, and CaMKIIα T305A/T306A in slice culture (Fig. 10a, b).
Overexpressing WT CaMKIIα had no effect on synaptic
transmission (Fig. 10c, f), whereas overexpressing CaMKIIα
T305A/T306A caused a three-fold enhancement (Fig. 10d, f). The
constitutively active CaMKIIα T286D-T305A/T306A (CA CaM-
KIIα) mutant50 caused an identical enhancement (Fig. 10e, f).
However, the mechanisms by which these two constructs enhance
synaptic transmission are fundamentally different. As expected
the activity of CaMKIIα T286D-T305A/T306A is independent of
Ca2+/CaM and NMDAR activity (Fig. 10h, k). On the other
hand, the enhancement observed with CaMKIIα T305A/T306A is
entirely dependent on ongoing NMDAR activity, since incubation
of slices with APV prevented the enhancement (Fig. 10g, k). This
finding is consistent with the increased affinity of this mutation to
Ca2+/CaM. As a result cells expressing this mutant are more
sensitive than control neurons to the ongoing spontaneous
activity and NMDAR-dependent plasticity in slice cultures50.
Preventing CaMKIIα from binding to NMDARs with the
CaMKIIα I205K mutation completely abrogates its ability to
enhance synaptic transmission (Fig. 10i, k). Even more remark-
able is the finding that the enhancement caused by constitutively
active CaMKIIα T286D-T305A/T306A is also completely pre-
vented by the I205K mutation suggesting that the binding of
CaMKII to NMDARs is essential for the actions of CaMKII
(Fig. 10j, k). This finding highlights the fact that the presence of a
constitutively active kinase in the spine is not sufficient to
enhance synaptic function—it requires the precise targeting
provided by binding to NMDARs.
The findings also indicate that CaMKIIα T305A/T306A is
considerably more sensitive to Ca2+/CaM than WT CaMKIIα
and that its actions require NMDAR activation. Is NMDAR
activity only required initially, as would be predicted by the
model in which CaMKIIα activity becomes independent of Ca2+?
In this case, one would predict that the acute application of APV
would have little or no effect on the enhancement, once the
enhancement is initiated and locked in. We first examined the
acute application of APV on the enhancement caused by
expression of the constitutive active CaMKIIα T286D-T305A/
T306A. Neither short term (10 min) nor long-term (2 h)
application of APV had any effect on the enhancement (Fig. 10l).
In striking contrast, APV completely reversed the enhancement
caused by CaMKIIα T305A/T306A over a 2-hour period
(Fig. 10m). Interestingly, voltage-clamping cells at −70 mV
expressing CaMKIIα T305A/T306A in the absence of APV was
sufficient to reverse the enhancement over a 90-min period
(Supplementary Fig. 9). This is to be expected, since clamping the
cells prevents NMDAR activation. Similar results were obtained
when these experiments were carried out on the DKO back-
ground. Thus the enhancing action of CaMKIIα T305A/T306A
(Supplementary Fig. 10c, f) was absent in the presence of APV for
10DIV (Supplementary Fig. 10d, f) or for a short period (2 h)
(Supplementary Fig. 10e, f). An example of the time course of
APV’s action is shown in Supplementary Fig. 10g. As would be
expected the CaMKIIα T305A/T306A construct fully rescued
NMDA EPSCs on the DKO background (Supplementary Fig. 10h,
i). Thus our experiments failed to uncover a constitutive Ca2
+/CaM-independent component to the action of CaMKII.
Discussion
Despite the numerous studies that have been carried out on the
properties of CaMKII over that past two decades, much confusion
remains. In this study we took advantage of CRISPR technology
to systematically and rigorously probe the role of CaMKII in
synaptic function. CRISPR provides a way to relatively rapidly
and completely delete synaptic proteins53. Coupled with the use
of slice culture and in utero electroporation, along with simul-
taneous paired recordings, we were able to resolve a number of
the outstanding issues in this field. In brief, CaMKIIα, but not
CaMKIIβ, is required to maintain basal AMPAR and NMDAR
synaptic transmission. AMPAR transmission requires kinase
activity, but NMDAR transmission does not, indicating a scaf-
folding role for the CaMKII protein instead. LTP was abolished in
the absence of CaMKIIα and β, in the DKO, and with the
molecular replacement of the Thr296 - autophosphorylation null
mutant (T286A). All aspects of CaMKIIα signaling examined in
this study, except for the maintenance of NMDAR synaptic
currents, require binding to the NMDAR, emphasizing the
essential role of this receptor as a synaptic signaling hub. Finally,
evidence is presented that the maintenance of the CaMKII-
induced synaptic enhancement does not involve Ca2+-indepen-
dent kinase activity of CaMKII.
A number of the findings reported in this study differ quan-
titatively, and in some cases qualitatively, from many previous
studies, especially those using genetic approaches. For instance,
we find that deleting CaMKIIα fully blocks LTP and that dis-
rupting the interaction of CaMKII with the NMDAR entirely
prevents the synaptic actions of CaMKII. In addition, previous
genetic studies failed to observe changes in baseline transmission
of either the AMPAR or NMDAR EPSCs. One possibility is
compensation with the germline KOs. However, it is unclear how
this could occur. It seems most unlikely that CaMKIIβ could
compensate for the absence of CaMKIIα, because it is unable to
support LTP. The only clear difference between our study and
Fig. 4 Basal synaptic transmission and LTP in adult mice hippocampus require CaMKII. aMap of the CRISPR construct used to transduce the lentivirus and
mouse model used in the experiment. b Timeline of the experiment. c Scheme of the dual cell recording experiment approach. d Scatterplots show
amplitudes of AMPAR EPSCs for single pairs (open circles) of control and transfected cells of DKO (n= 6 pairs). Filled circle indicates mean ± SEM
(d, Control= 179.3 ± 13.3; DKO= 93.8 ± 14.6, p < 0.001). e Bar graph of ratios normalized to control (%) summarizing the mean ± SEM of AMPAR EPSCs
of values represented in d (51 ± 4.7, p= 0.02). f Scatterplots show amplitudes of NMDAR EPSCs for single pairs (open circles) of control and transfected
cells of DKO (n= 6 pairs). Filled circle indicates mean ± SEM (f, Control= 98 ± 17; DKO= 52.8 ± 9, p < 0.05). g Bar graph normalized to control (%)
summarizing the mean ± SEM of NMDAR EPSCs of values represented in f (62.9 ± 8.5, p= 0.04). h (Control, n= 6; DKO, n= 4, p= 0.01 at 35min). Scale
bars: 50 pA, 50ms. i Scheme of the dual cell recording experiment approach, in dentate gyrus. j Scatterplot showing amplitudes of AMPAR EPSCs for
single pairs (open circles) of control and transfected cells of DKO (n= 8 pairs). Filled circle indicates mean ± SEM. j Control= 140.9 ± 24; DKO= 75.1 ± 21,
p < 0.001. k Bar graph of ratios normalized to control (%) summarizing the mean ± SEM of AMPAR EPSCs of values represented in j (52.9 ± 11, p= 0.03). l
Plots showing mean ± SEM AMPAR EPSC amplitude of control (black) and transfected CRISPR_DKO (red) pyramidal neurons normalized to the mean
AMPAR EPSC amplitude before LTP induction (arrow) (Control, n= 6; DKO, n= 4, p= 0.01 at 30min). Gray plots represent mean ± SEM AMPAR EPSC
amplitude of LTP induction in APV 50 μM. Raw amplitude data from dual cell recordings were analyzed using Wilcoxon signed rank test (p values indicated
above). Normalized data were analyzed using a one-way ANOVA and p values calculated with the Mann−Whitney test (*p < 0.01). Mann−Whitney test
was also used to compare LTP at 35min (p values indicated above). Scale bars: 50ms, 50 pA
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most previous studies is that we used single cell manipulations,
whereas most previous studies used global genetic manipulations.
There are a couple studies, one on neuroligin54 and the other on
ephrin-B355 that directly compared these two conditions. They
found that global manipulations of these synaptic adhesion
molecules had no effect on synapse number, whereas single cell
manipulations did. They propose that there may be a transcellular
competitive process. However, it is unclear how such a
mechanism would work in the present study.
If CaMKII serves as a memory molecule by maintaining
enhanced synaptic transmission, one would expect that its dele-
tion would result in a deficit in synaptic transmission. Surpris-
ingly, CaMKII knockouts12,26 or CaMKIIα T286A knockin
mice13,14 display no change in baseline transmission, despite LTP
inhibition. Although early studies found little effect of classical
CaMKII inhibitors including peptides and small molecules on
baseline transmission9,10,22, more recent studies with new peptide
inhibitors have reported a depression in basal transmission23,24,
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but nonspecific effects, especially with bath application, con-
tribute substantially to the depression25.
In our hands, deletion of CaMKIIα alone or in combination
with CaMKIIβ (DKO) with CRISPR/Cas9 caused a dramatic
reduction (~50%) in AMPAR EPSCs together with a modest
reduction (~30%) in NMDAR EPSCs using both slice culture
preparations or following in utero electroporation. A previous
study presented evidence that the subunit composition of
NMDARs was altered in cells expressing CaMKIIα T286A56.
However, in our experiments we found no change in the decay
kinetics of the NMDAR EPSC in either CaMKIIα KO or in the
DKO. Deletion of CaMKIIβ had no effect on basal synaptic
transmission, in contrast to a modest reduction reported in a
previous study using shRNA19. This lack of effect is likely due to
the lower expression level of the protein, as well as its reduced
activity. However both electrophysiological LTP and two photon
sLTP after CRISPR_CaMKIIβ deletion, confirmed a fundamental
role of this subunit in LTP (Fig. 2 and Supplementary Fig. 5).
What might explain this seemingly contradictory result? As
described before, there is an excess of CaMKIIα compared to
CaMKIIβ5 at normal physiological levels. One possible explana-
tion is that, when we delete the β isoform the total amount of
CaMKII is substantially reduced such that the residual amount of
CaMKIIα is not sufficient for inducing LTP. Nevertheless, the
reduced levels of CaMKII would be sufficient to maintain basal
transmission. Only with more severe reduction in total CaMKII
levels do we see a reduction in basal transmission (see CaMKIIα
and DKO deletions (Fig. 1i and k)). Furthermore, deletion of
CaMKII in adult hippocampus caused a similar reduction. Thus it
is safe to conclude that the strength of excitatory synaptic
transmission is dependent on the presence of CaMKII throughout
life.
The unusually high amount of CaMKII in the brain and at
synapses raised early on the possibility that it might serve a
structural role. Indeed, recent evidence has emerged for kinase-
independent structural roles for CaMKIIβ3. Both the morpholo-
gical effects of deleting CaMKIIβ20 and the impairment of
CaMKIIα targeting to the PSD in the CaMKIIβ KO mouse can be
rescued by a kinase dead mutant of CaMKIIβ21. In the present
study CaMKIIα T286A and K42R failed to rescue AMPAR basal
synaptic transmission or LTP. However, they fully rescued
NMDAR basal synaptic transmission, indicating a kinase-inde-
pendent, structural/scaffolding role for CaMKII. Curiously, unlike all
of the other actions of CaMKII, which required binding of CaMKII
to the NMDAR, the rescue of the NMDAR current did not.
It is often stated in reviews that CaMKII is both necessary and
sufficient for LTP. However, the literature on the necessity of
CaMKIIα for LTP does not support such a strong conclusion.
While pharmacological9–11 and genetic data12–14,51 show that
inhibiting/deleting CaMKII causes a dramatic reduction in LTP,
in most studies significant potentiation remains, especially in the
genetic models. This raises the possibility of a CaMKII-
independent component to NMDAR-dependent LTP. We
found that deletion of CaMKIIα alone or together with CaMKIIβ
abolished LTP. However, in both of these manipulations, there is
a clear reduction in the NMDAR EPSC, raising the possibility
that some of the LTP deficit could result from this loss. To cir-
cumvent this issue we took advantage of our finding that CaM-
KIIα T286A and K42R fully rescue the NMDAR defect in the
DKO. The T286A mutation mimicked the effect of CaMKIIα
deletion, indicating that this subunit fully accounts for NMDAR-
dependent LTP. Recently it has been proposed that CaMKIIα
T286A retains some kinase activity and that cells expressing
T286A can show LTP when the stimulus frequency is increased
beyond that typically use for pairing-induced LTP (<2 Hz)57.
Much to our surprise, substantial LTP remained with the K42R
mutation, even though this mutant’s effect on baseline trans-
mission was identical to that of T286A. Taken together our
findings indicate that CaMKIIα can fully account for NMDAR-
dependent LTP. There is thus no need to postulate a CaMKII-
independent component.
In addition to the DKO having dramatic effects on baseline
synaptic transmission, deleting both isoforms also caused clear
changes in dendritic spine morphology. Although the density of
spines was unaltered, the size of the spine head was reduced and
the spine neck became longer. The reduction in spine head size is
consistent with the hypothesis that AMPAR number is directly
related to spine size37 and the reduction in mEPSC amplitude.
In addition to its role in spine morphology, CaMKII is also
critical for sLTP. Uncaging glutamate caused a rapid increase in
spine volume that relaxed over a 6−8 min period to a stable
enhancement, similar to previous studies37. In DKO neurons or
neurons lacking either CaMKIIα or β the size of the transient
enhancement was unaltered, but the decay back to baseline was
more rapid and returned to baseline in ~4 min. Neurons
expressing the CaMKIIα T286A mutant on DKO background
decayed back to baseline more slowly (8–10 min), similar to the
kinetics of the transient phase in WT neurons. These deletion
studies confirm the fundamental role of CaMKII in
sLTP11,36,37,58. However, the early transient enhancement was
independent of CaMKII, but entirely dependent on NMDAR
activation and on Ca2+. These finding suggest that Ca2+ can
directly increase spine volume, presumably by directly engaging
the actin cytoskeleton59,60. However, the physiological relevance
of this CaMKII-independent spine enlargement remains unclear,
since pairing induced LTP does not induce a rapid transient
Fig. 5 CaMKIIα T286A and K42R mutated forms rescue NMDAR, but not AMPAR, EPSCs or sLTP. a Timeline of the experiment. b Scheme of the structural
organization of CaMKIIα showing point mutations (K42R dark green and T286A light green). c, d Scatterplots showing amplitudes of AMPAR EPSCs for
single pairs (open circles) of control and transfected cells of DKO + CaMKIIα T286A (c, n = 18 pairs), and DKO + CaMKIIα K42R (d, n = 23 pairs). Filled
circle indicate mean ± SEM. (c, Control = 110.9 ± 17.8; DKO + CaMKIIα T286A = 49.7 ± 9.1 p < 0.0001; d, Control = 148.4 ± 20.4; DKO + CaMKIIα K42R
= 53.5 ± 7.5 p < 0.0001). e Bar graph of ratios normalized to control (%) summarizing the mean ± SEM of AMPAR EPSCs of values represented in c (43.9
± 6, p= 0.0009) and d (45.4 ± 5.1, p < 0.0001). DKO data (red bar) from Fig. 1l are included in the graph. f, g Scatterplots showing amplitudes of NMDAR
EPSCs for single pairs (open circles) of control and transfected cells of DKO+ CaMKIIα K42R (f, n= 23 pairs), and DKO+ CaMKIIα T286A (g, n= 21
pairs). Filled circles indicate mean ± SEM. (f, Control= 76.1 ± 6.6; DKO+CaMKIIα K42R= 75.3 ± 8, p= 0.93; g, Control= 38.6 ± 3.8; DKO+ CaMKIIα
T286A= 32.6 ± 3, p= 0.078). h Bar graph of ratios normalized to control (%) summarizing the mean ± SEM of NMDAR EPSCs of values represented in f
(107 ± 13, p= 0.84) and g (86.8 ± 6.9, p= 0.70). DKO data (red bar) from Fig. 1p are included in the graph. i Fluorescence GFP image samples of spine
structural plasticity during sLTP. The red dot indicates the spot of glutamate uncaging. Scale bar 1 μm. j Long-term spine volume change of WT (black),
CaMKII DKO (red) and DKO+ CaMKIIα T286A (green). Each point represents the mean ± SEM % of volume change every 30 s. k Bar graph of averaged
volume change at 20min. Values represent mean ± SEM as % of baseline volume (Control= 145.5 ± 6; DKO= 100 ± 7.1; DKO+CaMKIIα T286A= 100.1
± 2.3). Number of samples (spines/neurons) is 14/8 for control cells; 10/6 for DKO, and 8/6 for T286A replacement. Raw amplitude data from dual cell
recordings were analyzed using Wilcoxon signed rank test (p values indicated above). Normalized data (including sLTP) were analyzed using a one-way
ANOVA followed by the Mann−Whitney test (***p < 0.0001; **p < 0.001). Scale bars: 50ms, 50 pA. See also Supplementary Fig. 4−6
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enhancement of AMPAR currents. Perhaps this transient phase
represents a CaMKII--independent exocytosis61 that is dependent
on SNARE proteins61,62. This raises the possibility that some
modulatory substance might be released during and immediately
after induction. The present findings that LTP and sLTP are both
absent from neurons lacking CaMKIIα and that exogenous con-
stitutively active CaMKII can fully mimic LTP15–17 confirm that
CaMKII is both necessary and sufficient for NMDAR-dependent
LTP. Again, there is no need to postulate the existence of
CaMKII-independent processes.
It has long been known that activity translocates CaMKII from
the cytosol to the PSD40,41 and that the primary binding partner
at the PSD is the GluN2B subunit of the NMDAR38–40. Over-
expression of a GluN2B subunit in which mutations in the C-tail
disrupt the binding of CaMKII to the NMDAR42 or generation of
a knockin mouse with similar mutations43 impairs LTP. To fur-
ther study the role of CaMKII binding to the NMDAR, we took
advantage of two point mutations in CaMKIIα (F98K and I205K)
that prevent binding to the NMDAR40,44. Much to our surprise
these CaMKIIα mutants, which have intact kinase activity,
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behaved identically to CaMKIIα T286A and K42R: they failed to
rescue AMPAR EPSCs in the DKO background, but rescued the
defect in NMDAR transmission. Furthermore, LTP was absent in
the CaMKIIα I205K mutant (Fig. 8). Perhaps even more sur-
prising is the finding that overexpression of the constitutively
active kinase (CaMKIIα T286D-T305A/T306A), which enhances
AMPAR responses three-fold, no longer had any effect on
synaptic responses when it harbored the I205K mutation. This
finding indicates that for CaMKII to function at the synapse it
must be targeted to a precise nanodomain by the NMDAR, which
thus presumably restricts its spatial influence.
Why is the disruption of CaMKIIα binding to the NMDAR in
our experiments using the CaMKIIα F98K and I205K mutations
more dramatic compared to disrupting binding with mutations in
the GluN2B C-terminal domain42,43? In addition to the difference
in experimental conditions, it is possible that the CaMKIIα F98K
and I205K mutations might also disrupt CaMKII binding to the
GluN1 subunit47 and other additional synaptic proteins45. To
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address this possibility we replaced GluN2B with a mutant that is
unable to bind to CaMKII. This mutant mimicked the effects of
deleting CaMKIIα, confirming that binding of CaMKIIα to the
NMDAR is, indeed, crucial for its synaptic actions. The NMDARs
tend to be clustered in the center of the synapse, whereas the
AMPARs are more concentrated around the periphery63,64. The
apparent requirement for CaMKII to be bound to the NMDAR to
recruit AMPARs to the synapse suggests that CaMKII exerts its
effects well beyond the center of the synapse. This might be
explained by the dynamic nature of synaptic proteins, such as
AMPARs and scaffolding proteins. In addition, CaMKII binding
to the NMDAR initiates a widespread remodeling of the PSD,
most likely involving the actin cytoskeleton58,65. Another issue
concerns stoichiometry. There are, on average, about 20
NMDARs per synapse compared to about 80−170 CaMKII
molecules per synapse66,67. Hence, it seems likely that CaMKII
interacts with additional PSD proteins, although the physiological
consequences of these interactions are unclear.
One of the more controversial topics in the LTP field concerns
the mechanism underlying its persistence. It has long been pos-
tulated that the “memory” is due to the unique biochemical
properties of the CaMKII protein, in which the transient Ca2
+/CaM activation of CaMKII initiates its autophosphorylation
converting the kinase into a Ca2+-independent constitutively
active form1,6,8. The fact that we observe a large decrease in
baseline AMPAR transmission following the deletion of CaMKII
would be consistent with this model. However, other experiments
have raised serious concerns. If constitutive CaMKII activity is
responsible for LTP maintenance one would expect that blockade
of CaMKII activity after the induction of LTP should reverse the
potentiation. However, this is generally not the case9,11,57,68, but
see ref. 24. To examine this issue we took advantage of CaMKIIα
In utero EP
IE 15.5
+ Replacement
AMPAR EPSCs
300
200
Tr
an
sf
ec
te
d 
(pA
)
N
or
m
. (t
ran
sf.
/co
nt.
)
100
600
500
2 Hz 90 s
1 2
2
1
1 2E
PS
C 
(%
 ba
se
lin
e)
400
300
200
100
0
0 10
Control In APV
DKO + l205K
20 30 40
Time (min)
100
100
50
Tr
an
sf
ec
te
d 
(pA
)
N
or
m
. (t
ran
sf.
/co
nt.
)
50
150
0 0
0 50 100
Co
ntr
ol
CR
ISP
R_
DK
O
DK
O+
l20
5K
Control (pA)
NMDAR EPSCs
NMDAR summary
150
100
50
0
**
***
0
0 100 200 300
Co
ntr
ol
CR
ISP
R_
DK
O
DK
O+
l20
5K
*** ***
Control (pA)
DKO + CaMKIIα l205K LTP
DKO + CaMKIIα l205K AMPAR summary
Recording
P20-P28
I205K
lle205
274 314 475
Kinase domain Regulatory domain
Gene deletion
DKO + CaMKIIα l205K
a b
c d e f
g
Fig. 8 CaMKIIα binding to GluN2B is critical for LTP. a Timeline of the experiment. b Scheme of the structural organization of CaMKIIα showing the point
mutation (I205K light green). c Scatterplot showing amplitudes of AMPAR EPSCs for single pairs (open circles) of control and transfected cells of DKO+
CaMKIIα I205K (c, n= 10 pairs). Filled circle indicates mean ± SEM (c, Control= 155.2 ± 20.7; DKO+ CaMKIIα I205K= 59.8 ± 10.8, p < 0.0001). d Bar
graph of ratios normalized to control (%) summarizing the mean ± SEM of AMPAR EPSCs of values represented in c (39.9 ± 6.1, p= 0.0007). DKO data
(red bar) from Fig. 2f are included in the graph. e Scatterplot showing amplitudes of NMDAR EPSCs for single pairs (open circles) of control and
transfected cells of DKO+ CaMKIIα I205K (d, n= 9 pairs). Filled circle indicates mean ± SEM (e, Control= 55.3 ± 11.7; DKO+ CaMKIIα I205K= 43.4 ±
6.2, p= 0.17). f Bar graph of ratios normalized to control (%) summarizing the mean ± SEM of NMDAR EPSCs of values represented in e (90.3 ± 11.2, p=
0.38). DKO data (red bar) from Fig. 6e are included in the graph. g Plots showing mean ± SEM AMPAR EPSC amplitude of control (black) and transfected
(green) CRISPR_DKO+CaMKIIα I205K pyramidal neurons normalized to the mean AMPAR EPSC amplitude before LTP induction (arrow) (Control, n=
12; DKO+ CaMKIIα I205K, n= 9, p= 0.0049 at 35min). Sample AMPAR EPSC current traces from control (black) and electroporated neurons (green)
before and after LTP are shown to the right of each graph. Gray plots represent mean ± SEM AMPAR EPSC amplitude of LTP induction in APV 50 μM. Raw
amplitude data from dual cell recordings were analyzed using Wilcoxon signed rank test (p values indicated above). Normalized data were analyzed using a
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T305A/T306A mutations, which makes CaMKII highly sensitive
to Ca2+/CaM. Expression of this construct caused a three-fold
enhancement in AMPAR currents. One might expect this
enhancement to be initially driven by Ca2+/CaM, but, via phos-
phorylation of T286, CaMKII should become constitutively
active. We found that application of APV reversed the
enhancement indicating that spontaneous NMDAR activation
drives the enhancement. Importantly, application of APV for as
short a time as an hour entirely reversed the enhancement.
Although we could find no evidence for a Ca2+/CaM-indepen-
dent constitutive component to the CaMKII enhancement, these
experiments do not exclude such a mechanism. As proposed by
Lisman et al.69, CaMKII is postulated to assume three distinct
activation states that depend on the magnitude, and possibly the
duration, of the Ca2+ signal. The activation of CaMKII with weak
signals fails to initiate autophosphorylation and the kinase inac-
tivates rapidly (0.1–0.2 s) as calmodulin dissociates from the
kinase. This would explain the moment-to-moment signaling of
NMDARs in the absence of any lasting changes70. With modest
Ca2+ elevation autophosphorylation will occur. The duration of
the signal is proposed to depend on the phosphatase activity,
which can dephosphorylate CaMKII over a time scale of min-
utes71. Finally, it is proposed that with robust elevation in Ca2+,
as occurs with LTP, the rate of autophosphorylation is greater
than the rate of dephosphorylation. A conservative interpretation
of our findings with the T305A/T306A mutation is that the level
of CaMKII activation fails to reach threshold for favoring
autophosphorylation over dephosphorylation.
Our work emphasizes the central role that CaMKIIα plays in
excitatory synaptic transmission. It is required both in early
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development and in the adult to maintain basal synaptic
AMPARs via its kinase activity and NMDARs via a kinase-
independent mechanism. CaMKIIα can fully account for
NMDAR-dependent LTP. CaMKIIβ plays no role in maintaining
basal synaptic transmission, but can modulate CaMKIIα-
dependent LTP. sLTP involves a fast-transient spine enlarge-
ment which is independent of CaMKII, but dependent on Ca2+,
followed by a persistent CaMKII-dependent enlargement. We
were unable to identify a Ca2+/CaM-independent constitutive
component to the CaMKII enhancement. Finally all the synaptic
effects of CaMKIIα that we examined, except the maintenance of
baseline NMDAR currents, required its binding to NMDARs,
establishing the CaMKII/NMDAR protein complex as an essen-
tial synaptic signaling hub, controlling numerous fundamental
aspects of excitatory synaptic transmission.
Methods
DNA constructs. Design and screening of gRNAs for the CRISPR constructs were
performed as previously described53. Briefly for the screening of CaMKIIα and β
gRNA sequences for potential off-target effects, we used the Cas9 design target tool
(http://crispr.mit.edu). The human codon-optimized Cas9 and chimeric gRNA
expression plasmid (px458) as well as the lentiviral backbone plasmid (lentiCRISPR
v.2) both developed by the Zhang lab72–74 were obtained from Addgene. Lenti-
CRISPR was modified inserting an EGFP sequence after a p2a promoter to detect
the expression level after infection. After screening several gRNAs the primers used
to design the specific gRNA targets were: CaMK2a#1 forward (5′ to 3′) CACC G
ctccaggggagccttctccg; CaMK2a#1 reverse (3′ to 5′) AAAC cggagaaggctcccctggag C;
CaMK2a#2 forward (5′ to 3′) CACC Gcaggtgatggtagccatcc; CaMK2a#1 reverse (3′
to 5′) AAAC ggatggctaccatcacctgC; CaMK2b#1 forward (5′ to 3′) CACC
Gtgtcatggaggcgtactgcg; CaMK2b#1 reverse (3′ to 5′) AAAC cgcagtacgcctccatgacaC.
All gRNAs were accurately chosen to target both mouse and rat genes. In particular
CaMK2a#1 targets a region in which the PAM sequence is in an intron of the
catalytic region. CaMK2a#2 targets part of the UTR region of exon 1. CaMK2b#1
gRNA targets a region between intron 1 and exon 1. Thus all gRNAs are not
targeting the coding region of the CaMKII plasmid, allowing replacements with wt
constructs. pRSV-CaMKIIα was a gift from Richard Maurer (Addgene plasmid #
45064) and GFP-C1-CAMKIIβ was a gift from Tobias Meyer (Addgene plasmid #
21227). Both plasmids were sub-cloned into a pCAGGS vector followed by an IRES-
GFP or mCherry sequence for biolistic transfection. All CaMKIIα mutations were
done by overlapping PCR from the pCAGGS-CaMKIIα−IRES-GFP or mCherry.
For all replacement experiments to target both CaMKII isoforms we sub-cloned the
two gRNAs including the following chimeric RNA into a pFUGW mCherry or GFP
plasmid, through PCR amplification and insertion into the FUGW plasmid using
BstbI and EcoRI restriction sites. Primers for CaMK2a gRNA were: forward
TTAATCGTACGAATTCgagggcctatttccc; reverse GGGTTAATTAATTCGAATGG
CGTTCTATTGA. Primers for CaMK2b gRNA: forward TAGTAACGCCATTGC
AAgagggcctatttccc; reverse GGGTTAATTAATTCGAATGGCGTTACTATTGA.
All cloning was achieved by In-Fusion HD Cloning System (Clontech). For over-
expression experiments a pFUGW vector expressing only GFP was coexpressed
with pCAGG-IRES-mCherry constructs to enhance the identification of transfected
neurons, and served as a control vector for spine imaging.
Sequence of CaMKIIα, β and GluN2B used in all replacements and primers to
make the mutations. Amino acidic sequence of the CaMKIIα (Rattus Norvegicus)
used in all experiments:
MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSA
RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE
YYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLAD
FGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG
YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT
AAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTTMLATRN
FSGGKSGGNKKNDGVKESSESTNTTIEDEDTKVRKQEIIKVTEQLIEAISNGDF
ESYTKMCDPGMTAFEPEALGNLVEGLDFHRFYFENLWSRNSKPVHTTILNPH
IHLMGDESACIAYIRITQYLDAGGIPRTAQSEETRVWHRRDGKWQIVHFHRS
GAPSVLPH.
All mutations were done from this sequence using overlapping PCR of a
pCAGGS-CaMKIIα in a pCAGGS-IRES-GFP or mCherry plasmid digested with
NheI and XhoI. Common outside primers were: forward (5′ to 3′) 5′-GGACTCA
GATCTCGAGATGGCTACCATCACC-3′; Reverse (3′ to 5′) GAAGCTTGAGCT
CGAGTCAATGGGGCAGGAC. The following primers were used for the K42R
mutation: inside forward GAGTATGCTGCCAGGATTATCAACAC; inside
reverse GAGTATGCTGCCAGGATTATCAACAC. For T286A mutation: inside
forward GACAGGAGGCAGTGGACTGCCTGAAG; inside reverse
CTTCAGGCAGTCCACTGCCTCCTGTC. For T286D: inside forward
GACAGGAGGACGTGGACTGCCTGAAG; inside reverse
CAGTCCACGTCCTCCTGTCTGTGCAT. For I205K: inside forward
GGCGTCATCCTGTAAATCTTGCTGGTT; inside reverse:
AACCAGCAAGATTTACAGGATGACGCC. For F98K: inside forward:
TGGTGGGGAGCTGAAAGAAGACATTGT; inside reverse:
AACCAGCAAGATTTACAGGATGACGCC. For T305A/T306A: inside forward
GCCATCCTCGCCGCTATGCTGGCCACC; inside reverse
ACAATGTCTTCTTTCAGCTCCCCACCA. For T305D/T306D; inside forward
GCCATCCTCGATGACATGCTGGCCACC; inside reverse
GGTGGCCAGCATGTCATCGAGGATGGC. For T305A/T306D: inside forward
GCCATCCTCGATGACATGCTGGCCACC; inside reverse
GGTGGCCAGCATGTCATCGAGGATGGC. For T305D/T06A: inside forward
GCCATCCTCGACGCCATGCTGGCCACC; inside reverse
GGTGGCCAGCATGGCGTCGAGGATGGC. Some of the mutations were
combined (e.g. T286D-T305A/T306A) using the first mutated form as backbone.
Amino acidic sequence of the CaMKIIβ (isoform 2 Rattus Norvegicus) used in
the experiments: MATTVTCTRFTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYA
AKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTG
GELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASK
CKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIW
ACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN
QMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETVECLKKFNARRKLK
GAILTTMLATRNFSVGRQTTAPATMSTAASGTTMGLVEQAKSLLNKKADG
VKPQTNSTKNSSAITSPKGSLPPAALEPQTTVIHNPVDGIKESSDSTNTTIEDED
AKARKQEIIKTTEQLIEAVNNGDFEAYAKICDPGLTSFEPEALGNLVEGMDFH
RFYFENLLAKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQS
EETRVWHRRDGKWQNVHFHCSGAPVAPLQ,
For GluN2B replacement experiments overlapping PCR of a p-CAGGS-
GluN2B-GFP plasmid was used. In particular, mutated GluN2B was inserted in a
p-CAGGS-IRES-mCherry plasmid digested with NheI and XhoI. Outside primers,
forward: ATTCGCGGCCGCTAGCATGAAGCCCAGCGC; reverse: GAAGCTT
GAGCTCGAGTCAGACATCAGACTC. Inside primers, forward: GAAGAATCG
GAACAAAGCTCGCCAACAGCACTCCTACGACA; reverse: TGTCGTAGGAG
TGCTGTTGGCGAGCTTTGTTCCGATTCTT.
Fig. 9 Replacement of GluN2B that does not bind CaMKIIα confirms the role of this interaction in basal transmission. a. Timeline of experiment. b Scheme
of GluN2B region critical for CaMKII binding (green wild type; red mutated). c–f Scatterplots showing amplitudes of AMPAR EPSCs for single pairs (open
circles) of control and transfected cells of CRISPR_GluN2B (c, n= 12 pairs), CRISPR_GluN2B+GluN2B (d, n= 10), CRISPR_GluN2B+GluN2Bmut (e, n=
14 pairs), and CRISPR_GluN2B+GluN2Bmut+ CaMKIIα T305A/T306A (f, n= 13 pairs). Filled circles indicate mean ± SEM (c, Control= 89.38 ± 17.50;
CRISPR_GluN2B= 174 ± 27.83, p= 0.01; d, Control= 78.9 ± 10.8; CRISPR_GluN2B+GluN2B= 99.3 ± 14.8, p= 0.28; e, Control= 148.4 ± 22.7;
CRISPR_GluN2B+GluN2Bmut= 75.8 ± 18.6, p= 0.01; f, Control= 139.0 ± 16.6; CRISPR_GluN2B+GluN2Bmut+ CaMKIIα T305A/T306A= 92 ± 20.2, p
= 0.07). g−j Scatterplots showing amplitudes of NMDAR EPSCs for single pairs (open circles) of control and transfected cells of CRISPR_GluN2B (g, n=
12 pairs), CRISPR_GluN2B+GluN2B (h, n= 10 pairs), CRISPR_GluN2B+GluN2Bmut (i, n= 14 pairs), and CRISPR_GluN2B+GluN2Bmut+ CaMKIIα
T305A/T306A (j, n= 13 pairs). Filled circles indicate mean ± SEM (g, Control= 54.7 ± 14.4; CRISPR_GluN2B= 15.5 ± 4, p= 0.016; h, Control= 53.2 ±
10.2; CRISPR_GluN2B+GluN2B= 61.8, p= 0.58; i, Control= 54.15 ± 10.87; CRISPR_GluN2B+GluN2Bmut= 42.5 ± 10.4, p= 0.45; j, Control= 49.5 ± 9.3;
CRISPR_GluN2B+GluN2Bmut+ CaMKIIα T305A/T306A= 41.4 ± 6.7, p= 0.48). k Bar graph of ratios normalized to control (%) summarizing the mean
± SEM of AMPAR EPSCs of values represented in c (180 ± 31.1, p= 0.02), d (129 ± 20.4, p= 0.22), e (48.5 ± 13.3, p= 0.005) and f (68.3 ± 14.6, p= 0.04).
Values for CaMKIIα T286A (Fig. 5e) and CaMKIIα T305A/T306A (Suppl. Figure 10) replacements are included (% of control: 45.4 ± 5 and 250 ± 30). l Bar
graph of ratios normalized to control (%) summarizing mean ± SEM of NMDAR EPSCs of values represented in g (28.8 ± 14.8, p= 0.0002),
h (123 ± 22.6, p= 0.60), i (90.3 ± 11.1, p= 0.98) and j (89.9 ± 16, p= 0.74). Raw amplitude data from dual cell recordings were analyzed using Wilcoxon
signed rank test (p values indicated above). Normalized data were analyzed using a one-way ANOVA followed by the Mann−Whitney test (***p < 0.0001;
**p < 0.001; *p < 0.01). Scale bars: 50ms, 50 pA
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Slice culture, transfection, and CaMKII molecular replacement. Organotypic
hippocampal slice cultures were prepared from P6-8 rat brains and transfected with
sparse biolistic transfections as previously described75,76. Briefly, 50 μg of each
plasmid DNA was coated on 1 μm diameter gold particles in 0.5 mM spermidine,
precipitated with 0.1 mM CaCl2, and washed four times in pure ethanol. The gold
particles were coated onto PVC tubing, dried using ultra-pure N2 gas, and stored at
4 °C in desiccant. DNA-coated gold particles were delivered with a Helios Gene
Gun (BioRad). Constructs were transfected at DIV2. After 10–12 days of trans-
fection, neurons transfected with CRISPR constructs could be identified by GFP or
mCherry epifluorescence.
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In utero electroporation. In utero electroporation was performed as previously
described77. E15.5 pregnant WT (CD-1) mice were anesthetized with 2% isoflurane
in O2 and buprenorphine (Reckitt Benckiser Healthcare) and meloxicam (Boeh-
ringer Ingelheim) were used for analgesia. Embryos were exposed and injected
with~1.5 µl of mixed plasmid DNA with Fast Green (Sigma Aldrich) into the
lateral ventricle via a beveled micropipette. Embryos were exposed and injected
with ~2 µg/µl of the pFUGW-CaMKIIDKO-mCherry, px458 and pCAGGS- plas-
mids. Each embryo was electroporated with five 40 V pulses of 50 ms, delivered at
1 Hz, using platinum tweezertrodes in a square-wave pulse generator (BTX Har-
vard Apparatus). The positive electrode was placed in the lower right hemisphere
and the negative electrode placed in the upper left hemisphere. Following elec-
troporation, the embryos were placed back into the abdominal cavity and
abdominal muscle and skin were sutured. All experiments were performed in
accordance with established protocols approved by the University of California,
San Francisco’s Institutional Animal Care and Use Committee.
Lentivirus production. Three T-75 flasks of rapidly dividing HEK293T cells
(ATCC) were transfected with 27 μg lentiCRISPR v.2-GFP for single CaMKII
isoforms gRNAs or pFUGW-CaMKIIDKO-mCherry, plus helper plasmids pVSV-
G (18 μg) and psPAX2 (27 μg) using FuGENE HD (Promega). DNA was incubated
with 210 μL FuGENE HD in 4.5 ml Opti-MEM (Life Technologies) before trans-
fection, according to the manufacturer’s directions. Forty hours later, supernatant
was collected, filtered, and concentrated using the PEG-it Virus Precipitation
Solution (System Biosciences) according to the manufacturer’s directions. The
resulting pellet was resuspended in 400 μL Opti-MEM or PBS, flash-frozen, and
stored at −80 °C.
Neuronal culture transduction and western blot. Dissociated cultures of post-
natal rat hippocampal neurons were transduced with freshly made viral super-
natant at DIV4. For western blot analysis, neurons (DIV18) were lysed in 150 mM
NaCl, 50 mM Tris-HCl, pH 8.0, 1% TX-100, and protease inhibitors (Roche)
including 1 mM EGTA and 1mM PMSF. After sedimentation at 14,000 g to
remove nuclei and cell debris, 5 μg protein was separated by electrophoresis
through polyacrylamide, transferred to nitrocellulose, and the membranes immu-
noblotted for CaMKIIα (1 µg/mL, Enzo, monoclonal 6G9), CaMKIIβ (1 µg/mL,
Abcam ab34703), β-actin (1 µg/mL, Millipore 4C2), β-tubulin (1 µg/mL, Millipore
AA2) and the appropriate secondary antibodies conjugated to IRDye800 (Rock-
land). The membrane was imaged with a LICOR system (Odyssey).
Adult mice viral injections. For adult CaMKII DKO experiments Rosa26-Cas9
knock-in mice were used. Mice of both sexes with FVB/NJ congenic background
were purchased from Jackson labs (Stock No. 026558). These mice constitutively
express Cas9 and GFP. Viral injections of the pFUGW-CaMKIIDKO-mCherry
lentivirus were performed at P48 to P56. Mice were anesthetized with isoflurane
and immobilized on a stereotaxic frame. Bilateral injections of lentiviral vectors
into the CA1 Stratum Radiatum (AP: −2.00 mm, ML: +/−1.50 mm, DV: −1.50
mm, relative to Bregma), were conducted delivering 250 nL per hemisphere at a
rate of 500 nL/min via a Hamilton 88011 syringe driven by a Micro4 microsyringe
pump (World Precision Instruments). All experiments were performed in accor-
dance with established protocols approved by the University of California, San
Francisco’s Institutional Animal Care and Use Committee. Acute hippocampal
slices were prepared for recording 21 days later. Transfected pyramidal neurons in
area CA1 were identified by morphology and location. Some slices presented
transfection in the CA3, which we used as a proof of concept to study the
importance of CaMKII in a different neuronal type.
Electrophysiology. Whole-cell recordings in area CA1 were done by simulta-
neously recording responses from a fluorescent transfected neuron and a neigh-
boring untransfected control neuron. Pyramidal neurons were identified by
morphology and location. Series resistance was monitored online, and recordings in
which series increased to >30MΩ or varied by >50% between neurons were dis-
carded. Dual whole-cell recordings measuring evoked EPSCs used an extracellular
solution bubbled with 95% O2/ 5% CO2 consisting of (in mM) 119 NaCl, 2.5 KCl, 4
CaCl2, 4 MgSO4, 1 NaH2PO4, 26.2 NaHCO3, 11 Glucose. 100 μM picrotoxin was
added to block inhibitory currents and 0–2 μM 2-Chloroadenosine was used to
control epileptiform activity in organotypic slices. Intracellular solution contained
(in mM) 135 CsMeSO4, 8 NaCl, 10 HEPES, 0.3 EGTA, 5 QX314-Cl, 4 MgATP, 0.3
Na3GTP, 0.1 spermine. A bipolar stimulation electrode (FHC) was placed in stra-
tum radiatum, and responses were evoked at 0.2 Hz. Peak AMPAR currents were
recorded at −70mV. NMDAR currents measured at +40mV and were temporally
isolated by measuring amplitudes 100ms following the stimulus. Paired-pulse ratio
was determined by delivering two stimuli 40 ms apart and dividing the peak
response to stimulus 2 by the peak response to stimulus 1. mEPSCs were isolated by
adding 0.5–1 μM TTX to the recording solution to block evoked potentials and were
analyzed off-line with custom software (IGOR Pro). To minimize runup of baseline
responses during LTP, cells were held cell-attached for 1–2min before breaking into
the cell. LTP was induced by holding neurons at 0 mV during a 2-Hz stimulation of
Schaffer collaterals for 90 s. Dual whole-cell recordings in Dentate Gyrus were done
by simultaneously recording responses from a fluorescent transfected neuron and
neighboring untransfected control neuron.
2P microscopy imaging and measurements of sLTP in single spines. Hippo-
campal slices were biolistically transfected with pFUGW-GFP for control,
pFUGW-CaMKIIDKO-GFP, Cas9 (px 330) for DKO and pFUGW-CaMKIIDKO-
GFP, Cas9 (px 330) and pCAGSS-CaMKIIαT286A-mCherry for replacement.
Slices were maintained at room temperature (r.t. 25–27 °C) in a continuous per-
fusion of Mg-free artificial cerebrospinal fluid (ACSF) containing (in mM): 119
NaCl, 2.5 KCl, 4 CaCl2, 26.2 NaHCO3, 1 NaH2PO4 and 11 glucose, 1 µM tetro-
dotoxin, 50 µM picrotoxin and 4-methoxy-7-nitroindolinyl-caged L-glutamate
(MNI-glutamate, 2.5 mM, Tocris), equilibrated with 5% CO2/95% O2. Imaging was
performed at 10−14 DIV in primary or secondary dendrites from the distal part of
the main apical dendrite of CA1 pyramidal neurons. Neurons were visualized using
a two-photon imaging system (Bruker, Ultima II) powered by two Ultra II fem-
tosecond lasers (Coherent). Neurons were imaged with a 910 nm excitation source,
and GFP fluorescence was collected on R9110 photomultiplier tubes in epi- and
transfluorescence configurations, downstream of 550/100 bandpass filters. Scan-
ning interference contrast images of slice morphology was acquired with a pho-
tomultiplier tube downstream of a 770 nm longpass filter to ensure that all
uncaging sites were within 15 µm of the slice surface.
To induce sLTP, MNI glutamate was photolyzed using a 720 nm excitation
source (7.5 mW at the focal point). sLTP was induced by 0.5 ms pulses at 0.5 Hz,
with uncaging pulses positioned close to the tip of the spine. Images were obtained
at the Nyquist resolution limit, with four images averaged every second. For the
long-term sLTP, a z-stack image every 30 s was taken in order to have a precise
reconstruction of the spine changes. All analysis was done using Fiji (ImageJ)
software. For analysis two different methods were used: (i) for short-term analysis
the spine of interest was selected by a circle and mean fluorescence was measured
using ROI manager multi measure. The values were normalized to the first 15
frames of baseline (F0) before the uncaging. (ii) For long-term analysis, head
diameter was obtained using full width tenth-maximum (FWTM) measurements
based on Gaussian fits to approximate manual head measurement, using the curve
fitter plug-in. The spine head diameter was assessed every 30s from a single optical
Fig. 10 NMDAR-dependent and independent constitutive actions of CaMKIIα. a Timeline of the experiment. b Scheme of the structural organization of
CaMKIIα showing the point mutations (I205K red; T286D blue; T305A/T306A green). c−e Scatterplots showing amplitudes of AMPAR EPSCs for single
pairs (open circles) of control and transfected cells of overexpressed WT CaMKIIα (c, n= 9 pairs), sensitive CaMKIIα T305A/T306A (d, n= 17 pairs) and
constitutively active CaMKIIα T286D-T305A/T306A (e, n= 17 pairs). Filled circles indicate mean ± SEM (c, Control= 92.4 ± 12.3; CaMKIIα= 87.5 ± 13.9,
p= 0.83; d, Control= 101.2 ± 16.3; CaMKIIα T305A/T306A= 230.7 ± 23.4, p= 0.0005; e, Control= 101.5 ± 14.1; CaMKIIα T286D-T305A/T306A=
219.1 ± 26, p= 0.0005). f Bar graph of ratios normalized to control (%) summarizing the mean ± SEM of AMPAR EPSCs of values represented in c (99 ± 13
p= 0.59), d (309.8 ± 5.3, p < 0.0001) and e (249.8 ± 26.3, p= 0.001). g−j Scatterplots showing amplitudes of AMPAR EPSCs for single pairs (open
circles) of control and transfected cells of overexpressed sensitive CaMKIIα T305A/T306A (g, n= 12 pairs) and constitutive active CaMKIIα T286D-
T305A/T306A (h, n= 8 pairs), after 50 μM APV treatment; CaMKIIα T305A/T306A_I205K (i, n= 11 pairs) and CaMKIIα T286D-T305A/T306A_I205K
(j, n= 15 pairs). Filled circles indicate mean ± SEM (g, Control= 100 ± 15.3; CaMKIIα T305A/T306A= 113.6 ± 18.4, p= 0.27; h, Control= 124.2 ± 22.6;
CaMKIIα T286D -T305A/T306A= 296.9 ± 32, p= 0.007; i, Control= 99.3 ± 19.8; CaMKIIα T305A/T306A_I205K= 82.1 ± 8.3, p= 0.38; j, Control=
94.7 ± 12.2; CaMKIIα T286D-T305A/T306A_I205K= 62.9 ± 10, p= 0.10). k Bar graph of ratios normalized to control (%) summarizing the mean ± SEM
of AMPAR EPSCs of values represented in g (150.7 ± 30, p= 0.18), h (270.4 ± 39, p < 0.0001), (i) (100.2 ± 13.8, p= 0.35) and j (93.3 ± 20.3, p= 0.67
Mann−Whitney test). l Sample traces of AMPAR EPSCs of control (black) and CA CaMKIIα transfected (green) neurons before and after APV treatment.
m Sample traces of AMPAR EPSCs of control (black) and CaMKIIα T305A/T306A transfected (green) neurons before and after APV treatment. Raw
amplitude data from dual cell recordings were analyzed using Wilcoxon signed rank test (p values indicated above). Normalized data were analyzed using a
one-way ANOVA followed by the Mann−Whitney test (***p < 0.0001; **p < 0.001; *p < 0.01). Scale bars: 50ms, 50 pA. See also Supplementary Figs. 9
and 10
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section within the z-stack that best transected the head. Data were then processed
with Excel software and shown as graphs with GraphPad.
Spine morphology analysis. For spine morphology measurements, images were
acquired at DIV 7-9 using super-resolution microscopy (N-SIM Microscope Sys-
tem, Nikon). For use with the available inverted microscope and oil-immersion
objective lens, slices were fixed in 4% PFA/4% sucrose in PBS and washed 3× with
PBS. To amplify the GFP signal, slices were then blocked and permeablized in 3%
BSA in PBS containing 0.1% Triton-X and stained with primary antibody against
GFP (2 μg/mL, Life Technologies A-11122) followed by washes in PBSTx and
staining with Alexa 488-conjugated secondary (4 μg/mL, Life Technologies A-
11034). Slices were mounted in SlowFade Gold (Life Technologies) for imaging.
Only dendrites in the top 20 μm of the slice were imaged. Some slices were further
processed with an abbreviated SeeDB-based protocol78 in an attempt to reduce
spherical aberration, but no substantial improvement was seen. Images were
acquired with a ×100 oil objective in 3D-SIM mode using supplied SIM grating (3D
EX V-R ×100/1.49) and processed and reconstructed using supplied software (NIS-
Elements, Nikon). Morphological analysis was done on individual sections using
ImageJ to perform geometric measurements on spines extending laterally from the
dendrite. Spine neck widths were obtained from full width half-maximum mea-
surements based on Gaussian fits of line profile plots79. Neck length was measured
from the base of the spine to the base of the head. Head diameter was measured
perpendicular to the spine neck axis through the thickest part of the spine head.
Head diameter was obtained using full width tenthmaximum (FWTM) measure-
ments based on Gaussian fits to approximate manual head measurement. We note
that others79 have recently performed more precise morphological measurements;
we are constrained by available tools and tissue preparation.
Live confocal imaging. CA1 pyramidal neurons in organotypic hippocampal slice
cultures made from P6 rat pups were biolistically transfected with GFP or mCherry
tagged constructs ~18–20 h after plating. Confocal imaging was performed on live
tissue in HEPES-buffered ACSF (125 mM NaCl; 5 mM KCl; 10 mM D-Glucose; 10
mM HEPES; 2 mMMgSO4; 2 mM CaCl2; pH 7.3) 14 days after transfection using a
Nikon Spectral C1si confocal microscope with a NIR Apo ×40 W objective. Z-
stacks were made of 30 µm sections using EZ-C1 software (Nikon).
Immunofluorescence in dissociated neuronal cultures. Dissociated rat hippo-
campal neurons (embryonic day 20 (E20)) were sparsely transfected at DIV4–DIV7
with Lipofectamine 2000 (Life Technologies). Briefly, 0.2 μL of Lipofectamine and
0.2 μg of DNA (CRISPR_CaMKIIα and CRISPR_CaMKIIβ) were mixed in 50 μL of
Opti-mem (Life Technologies) per well following the manufacturer’s guidelines.
Neurons were then incubated in Opti-mem transfection medium for 2–3 h.
Transfection medium was aspirated, followed by 1× rinse with warm PBS and
replacement with fresh warm conditioned medium, then blocked and permeablized
in 3% BSA in PBS containing 0.1% Triton-X and stained with primary antibody (2
μg/mL) against CaMKIIα (Enzo Life Sciences) and CaMKIIβ (Abcam) followed by
washes in PBSTx and staining with Alexa 488-conjugated secondary (4 μg/mL, Life
Technologies A-11034). Covers were mounted in SlowFade Gold (Life Technolo-
gies) for imaging. Images were acquired with a ×40 objective and processed and
reconstructed using supplied software (NIS-Elements, Nikon). ImageJ was used for
post-hoc images editing.
Immunofluorescence microscopy. Surface receptors were analyzed using a
fluorescence-based antibody binding assay, as previously described80. Briefly,
hippocampal neurons were transduced with DKO virus at DIV 3 and transfected at
DIV 13 with GFP-GluN2B and, where indicated, with CaMKIIα rescue constructs.
Transfection was performed using Lipofectamine 2000 (Invitrogen), according to
the manufacturer’s instructions. At DIV17, surface receptors were labeled with
anti-GFP antibody for 15 min at room temperature, fixed with 4% PFA/4% sucrose
in PBS and stained with Alexa 488-conjugated secondary antibody (shown in
green). After permeabilization with 0.25% Triton X-100 in PBS, the intracellular
pool of receptors was labeled with anti-GFP antibody (2 μg/mL, Life Technologies
A-11122) followed by Alexa 647-conjugated secondary antibody incubation.
Images were collected using a Zeiss LSM 510 confocal microscope. Serial optical
sections of 0.35 μm intervals were used to create maximum projection images.
Fluorescence intensity of three independent areas per neuron was analyzed using
MetaMorph 6.0 software (Universal Imaging Corp). Intensity is presented as mean
± SEM of the ratio of surface/total intensity. Three to five independent experiments
were conducted and significance was analyzed using one-way ANOVA analysis (n
= number of cells).
Statistical analysis. Data analysis was carried out in Igor Pro (Wavemetrics),
Excel (Microsoft), and GraphPad Prism (GraphPad Software). Statistical analyses
were performed using the two-tailed Wilcoxon signed-rank test for all experiments
using paired whole-cell data, including all synaptic replacement and synaptic
overexpression data. In order to compare the different replacements to control and
to each mutated form we applied the one-way ANOVA. Normalization was
obtained by dividing both control and each condition to the value of the average of
the control. Once significance with ANOVA was detected, we applied the Mann
−Whitney U test to calculate the p value. LTP data were gathered from pairs of
control and experimental neurons; however, some cells were lost during the
experiment. Consequently the resulting datasets are a mix of interleaved and paired
data; thus, comparisons were made using the Mann−Whitney test. Summarized
data were presented in figures as mean+ SEM. In all experiments * is referred to
Mann−Whitney p values as follows: ***p < 0.0001; **p < 0.001; *p < 0.05.
Data availability. The data that support the findings of this study are available
from the corresponding authors upon reasonable request.
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